PERRY KUHN: Open Payments
NPI 1548666126 · LAKELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,920 in 101 payments from 17 companies in 2025. Trend: 2023 $919 · 2024 $1,861 · 2025 $1,920
Food & beverage: $1,920
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 40 | $683 |
| PFIZER INC. | 14 | $317 |
| Lilly USA, LLC | 11 | $211 |
| Phathom Pharmaceuticals, Inc. | 5 | $117 |
| GlaxoSmithKline, LLC. | 5 | $79 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $71 |
| AstraZeneca Pharmaceuticals LP | 3 | $65 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $65 |
| ABBVIE INC. | 3 | $51 |
| Novartis Pharmaceuticals Corporation | 3 | $48 |
Products named: Ozempic, Wegovy, ELIQUIS, MOUNJARO, JARDIANCE, VOQUEZNA, REXULTI, SHINGRIX.
Industry payments across FL — which companies pay providers there.
